WCN26-7255 PLACENTA DERIVED STEM CELLS FOR ACUTE KIDENY INJURY TO CHRONIC KIDNEY DISEASE PREVENTION: BIOMARKERS OF KIDNEY INJURY

Read full text Summarise with VIRAT
Authors: Agnė Gryguc, Justinas Mačiulaitis, Lukas Mickevicius, Arvydas Laurinavičius, Gintarė Vaičiulienė, Neringa Sutkevičienė, Vilma Zigmantaitė, Ramunė Grigalevičiūtė, Inga Arūnė Bumblytė, Romaldas Mačiulaitis
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Around 15% of cases of acute kidney injury (AKI) progress to chronic kidney disease (CKD). Although human placenta-derived mesenchymal stromal cells (hpMSCs) demonstrate anti-inflammatory properties, their long-term effects are unclear. This study aimed to evaluate the preventive effect of hpMSCs on AKI-to-CKD progression and to assess biomarkers sensitivity and correlation.

Fields of Study & Subjects

Acute Kidney Injury Research Mesenchymal stem cell research Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104520–104520
Publication date
25 March 2026
Language
EN